Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease - A Paradigm Shift?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6387|5|3|136-148

ISSN： 1573-398X

Source： Current Respiratory Medicine Reviews, Vol.5, Iss.3, 2009-08, pp. : 136-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Inflammatory Medications for Cystic Fibrosis Lung Disease: Selecting the Most Appropriate Agent

By Chmiel James F.   Konstan Michael W.  

Treatments in Respiratory Medicine, Vol. 4, Iss. 4, 2005-01 ,pp. : 255-273

Adis International

Access to resources Recommend Favorite

CHEMOKINE RECEPTORS IN A REGULATION OF INTERSTITIAL LUNG FIBROSIS AND INFLAMMATION

By Sterclova Martina   Vasakova Martina   Pavlicek Jan   Metlicka Monika   Krasna Eliska   Striz Ilja  

Experimental Lung Research, Vol. 35, Iss. 6, 2009-08 ,pp. : 514-523

Informa Healthcare

Access to resources Recommend Favorite

Current Status of Gene Therapy for Cystic Fibrosis Pulmonary Disease

By Kennedy M.J.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 5, 2002-01 ,pp. : 349-360

Adis International

Access to resources Recommend Favorite

Interleukin-1, Neutrophil Elastase, and Lipopolysaccharide: Key Pro- Inflammatory Stimuli Regulating Inflammation in Cystic Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 43-67

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation

By  

Medical Principles and Practice, Vol. 24, Iss. 4, 2015-04 ,pp. : 301-310

Karger

Access to resources Recommend Favorite